Fairvalue-Calculator Fairvalue-Calculator
EN DE

QT Imaging Holdings (QTI) Fair Value & Analysis

Healthcare · US · Market cap $49.0M

Price$3.80
Fair Value$0.4200
Upside-88.9%
Quality95/100
Evidence: Low Range $0.2700 – $0.5200

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

QT Imaging Holdings (QTI) currently trades at $3.80, while our model-based Fair Value estimate is $0.4200 — implying the stock looks roughly 88.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is QT Imaging Holdings (QTI) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.4200 versus a price of $3.80 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of QTI?
Our 21-model fair value for QT Imaging Holdings is $0.4200 (as of Jun 26, 2026), built from audited fundamentals. The current price is $3.80.
What is the quality score of QTI?
QT Imaging Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.